U.S. Senate · 117th Congress · S. 250
Fairness in Orphan Drug Exclusivity Act
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Bill CassidyR-LA
- Introduced
- February 4, 2021, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (2)
2 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Tammy BaldwinD-WI
- Jeanne ShaheenD-NH